Brokerages Set TG Therapeutics, Inc. (NASDAQ:TGTX) Price Target at $40.67
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among […]
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among […]
